[1]
Li Z, Zhang D, Dai Y, et al. Computed tomography-based radiomics for prediction of neoadjuvant chemotherapy outcomes in locally advanced gastric cancer: A pilot study. Chin J Cancer Res 2018;30:406-14. doi: 10.21147/j.issn.1000-9604.2018.04.03 [PubMed]
[2]
Deng J, Liang H, Sun D, et al. Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol 2008;22:835-9. doi: 10.1155/2008/761821 [PubMed]
[3]
Jeong JY, Kim MG, Ha TK, et al. Prognostic factors on overall survival in lymph node negative gastric cancer patients who underwent curative resection. J Gastric Cancer 2012;12:210-6. doi: 10.5230/jgc.2012.12.4.210 [PubMed]
[4]
Barros RH, Penachim TJ, Martins DL, et al. Multidetector computed tomography in the preoperative staging of gastric adenocarcinoma. Radiol Bras 2015;48:74-80. doi: 10.1590/0100-3984.2014.0021 [PubMed]
[5]
Habermann CR, Weiss F, Riecken R, et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 2004;230:465-71. doi: 10.1148/radiol.2302020828 [PubMed]
[6]
Li F, Li S, Wei L, et al. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment. Biomarkers 2013;18:632-7. doi: 10.3109/1354750X.2013.840800 [PubMed]
[7]
Shimada H, Noie T, Ohashi M, et al. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer 2014;17:26-33. doi: 10.1007/s10120-013-0259-5 [PubMed]
[8]
Ychou M, Duffour J, Kramar A, et al. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Dis Markers 2000;16:105-10. doi: 10.1155/2000/595492 [PubMed]
[9]
Jaehne J, Meyer HJ, Maschek H, et al. Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg 1992;127:290-4. doi: 10.1001/archsurg.1992.01420030052010 [PubMed]
[10]
Feng R, Lu S, Sah BK, et al. Serum miR-126 level combined with multi-detector computed tomography in the preoperative prediction of lymph node metastasis of gastric cancer. Cancer Biomark 2018;22:773-80. doi: 10.3233/CBM-181324 [PubMed]
[11]
Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more " personalized” approach to cancer staging. CA Cancer J Clin 2017;67:93-9. doi: 10.3322/caac.21388 [PubMed]
[12]
Furukawa K, Miyahara R, Itoh A, et al. Diagnosis of the invasion depth of gastric cancer using MDCT with virtual gastroscopy: comparison with staging with endoscopic ultrasound. AJR Am J Roentgenol 2011;197:867-85. doi: 10.2214/AJR.10.5872 [PubMed]
[13]
Morgagni P, Petrella E, Basile B, et al. Preoperative multidetector-row computed tomography scan staging for lymphatic gastric cancer spread. World J Surg Oncol 2012;10:197. doi: 10.1186/1477-7819-10-197 [PubMed]
[14]
Luo M, Lv Y, Guo X, et al. Value and impact factors of multidetector computed tomography in diagnosis of preoperative lymph node metastasis in gastric cancer: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2017;96:e7769. doi: 10.1097/MD.0000000000007769 [PubMed]
[15]
Wang M, Ye Y, Yang Q, et al. Pre-operative lymph node status of gastric cancer evaluated by multidetector computed tomography. Int J Clin Exp Med 2015;8:18213-24. [PubMed]
[16]
Saito T, Kurokawa Y, Takiguchi S, et al. Accuracy of multidetector-row CT in diagnosing lymph node metastasis in patients with gastric cancer. Eur Radiol 2015;25:368-74. doi: 10.1007/s00330-014-3373-9 [PubMed]
[17]
Kim SH, Kim JJ, Lee JS, et al. Preoperative N staging of gastric cancer by stomach protocol computed tomography. J Gastric Cancer 2013;13:149-56. doi: 10.5230/jgc.2013.13.3.149 [PubMed]
[18]
Almeida MFA, Verza L, Bitencourt AGV, et al. Computed tomography with a stomach protocol and virtual gastroscopy in the staging of gastric cancer: an initial experience. Radiol Bras 2018;51:211-7. doi: 10.1590/0100-3984.2017.0097 [PubMed]
[19]
Park SR, Kim MJ, Ryu KW, et al. Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: a viewpoint in the era of preoperative treatment. Ann Surg 2010;251:428-35. doi: 10.1097/SLA.0b013e3181ca69a7 [PubMed]
[20]
Kubota K, Suzuki A, Shiozaki H, et al. Accuracy of multidetector-row computed tomography in the preoperative diagnosis of lymph node metastasis in patients with gastric cancer. Gastrointest Tumors 2017;3:163-70. doi: 10.1159/000454923 [PubMed]
[21]
Yan C, Zhu ZG, Yan M, et al. Value of multidetector-row computed tomography in the preoperative T and N staging of gastric carcinoma: a large-scale Chinese study. J Surg Oncol 2009;100:205-14. doi: 10.1002/jso.21316 [PubMed]
[22]
Kawaguchi T, Komatsu S, Ichikawa D, et al. Nodal counts on MDCT as a surrogate marker for surgical curability in gastric cancer. Ann Surg Oncol 2012;19:2465-70. doi: 10.1245/s10434-012-2283-9 [PubMed]
[23]
Yang AP, Liu J, Lei HY, et al. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer. Clin Chim Acta 2014;437:183-6. doi: 10.1016/j.cca.2014.07.034 [PubMed]
[24]
Chen C, Chen Q, Zhao Q, et al. Value of combined detection of serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the diagnosis of gastric cancer. Ann Clin Lab Sci 2017;47:260-3. [PubMed]
[25]
Kim JH, Jun KH, Jung H, et al. Prognostic value of preoperative serum levels of five tumor markers (carcinoembryonic antigen, CA19-9, alpha-fetoprotein, CA72-4, and CA125) in gastric cancer. Hepatogastroenterology 2014;61:863-9. [PubMed]
[26]
Kim DY, Kim HR, Shim JH, et al. Significance of serum and tissue carcinoembryonic antigen for the prognosis of gastric carcinoma patients. J Surg Oncol 2000;74:185-92. doi: 10.1002/(ISSN)1096-9098 [PubMed]
[27]
Duraker N, Celik AN. The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA. J Surg Oncol 2001;76:266-71. doi: 10.1002/(ISSN)1096-9098 [PubMed]
[28]
Ucar E, Semerci E, Ustun H, et al. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer. Adv Ther 2008;25:1075-84. doi: 10.1007/s12325-008-0100-4 [PubMed]
[29]
Chen XZ, Zhang WK, Yang K, et al. Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population. Mol Biol Rep 2012;39:9031-9. doi: 10.1007/s11033-012-1774-x [PubMed]
[30]
Mattar R, Alves de Andrade CR, DiFavero GM, et al. Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer. Rev Hosp Clin Fac Med Sao Paulo 2002;57:89-92. doi: 10.1590/S0041-87812002000300001 [PubMed]
[31]
Yang XQ, Chen C, Peng CW, et al. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases. Med Oncol 2012;29:1030-6. doi: 10.1007/s12032-011-9967-z [PubMed]
[32]
Zhang Y, Yang J, Li H, et al. Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis. Int J Clin Exp Med 2015;8:11683-91. [PubMed]
[33]
Seevaratnam R, Cardoso R, McGregor C, et al. How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis. Gastric Cancer 2012;15 Suppl 1:S3-18. doi: 10.1007/s10120-011-0069-6 [PubMed]